STUDY DESIGN: Women with OUD were offered participation in our Mothers in Recovery Program (MIR), choosing either MAT or MSW using buprenorphine. MSW patients were admitted to inpatient (IP) Behavioral Health (BH) for a 7 day induction, then outpatient (OP) BH treatment for 6-18 weeks. Care included an OB work up, fetal monitoring during induction, management of co-occurring psychiatric, substance abuse, and other medical disorders. An MIR navigator followed the women through outreach, IP and OP care, working with MFM, psychiatry, OB and community agencies to ensure they had drug-free housing in a residential substance abuse treatment facility or in a home with a supportive family or friend. During the OP MSW phase, the patient had intensive OP treatment 7 days / week, with individual and group therapy, peer recovery support, case management, planning for discharge and support for the mother and infant. Intrapartum drug screening was routine. After delivery, NAS and meconium drug screening were performed to evaluate for fetal substance exposure. Postpartum (PP) follow-up included ongoing residential or OP treatment as indicated and periodic contact by the navigator. PP abstinence rates were self reported or obtained from the BH providers. RESULTS: MSW patients were significantly less likely to be opioid positive at delivery or to have an NAS affected baby. No adverse fetal or neonatal effects were noted due to maternal withdrawal. At 3 and 6 months postpartum there was no significant difference in the number of women still in recovery between the MAT and MSW groups. CONCLUSION: MSW with buprenorphine safely and effectively decreased NAS in newborns whose mothers had OUD. A multidisciplinary approach, using community resources, providing substance abuse treatment and supportive, drug free housing is essential for a drug free delivery and enhancing recovery in the long term.
577 Gestational weight gain and initiation and duration of breastfeeding among women with class III obesity Luke A. Gatta, Ann Tucker, Lemani Adkins, Anne Siegel, Courtney Mitchell, Emily Reiff, Sara Dotters-Katz Duke University, Durham, NC OBJECTIVE: Obese women stand to benefit the most from breastfeeding. Prior studies found an association between maternal obesity, delayed lactogenesis, and shorter duration of breastfeeding. We sought to understand the impact of excessive gestational weight gain (GWG), defined greater than IOM guidelines (>20lbs), on the initiation and duration of breastfeeding in women with class III obesity. STUDY DESIGN: Retrospective cohort of women with baseline BMI 40 (class III obesity) in the first trimester delivering a singleton term infant at a tertiary care center between 7/2013-7/2017. Pregnancies excluded for preterm delivery, multiple gestation, fetal anomalies, and when postpartum feeding information was unknown. The primary outcome was exclusive breastfeeding at discharge and at the time of 4-6 week postpartum visit. Secondary outcomes included any breastfeeding at discharge and postpartum visit and cessation of breastfeeding by the postpartum visit. Descriptive statistics used to compare women who gained more than IOM guidelines (mIOM) to those who gained <20 lbs (lIOM). Regression models performed to adjust for confounding factors. RESULTS: Of 298 women included in this study, 120 (40.27%) were in the mIOM arm. Women who gained mIOM were less likely to be multiparous and more likely to have a higher delivery BMI, greater delivery blood loss (EBL), and more likely to have a neonate admitted to the NICU (Table 1) . Exclusive breastfeeding at hospital discharge was not different between mIOM and lIOM women (58.05% v 41.95%, p¼0.45). Nor did gaining mIOM impact likelihood of exclusive breastfeeding at postpartum visit (63.64% v 36.36%, p¼0.33) (Table2). When controlling for NICU admission, parity, and EBL, the odds of exclusive breastfeeding at hospital discharge did not differ between women who gained mIOM compared to lIOM (AOR 1.2, 95% CI 0.76, 2.16), nor did breastfeeding rates at postpartum visit (AOR 0.79, 95% CI 0.48, 1.32). CONCLUSION: Among women with class III obesity, exclusive breastfeeding rates were high at both discharge and postpartum visit, and excessive gestational weight gain did not appear to impact this rate.
OBJECTIVE: Pregnant women with congenital heart disease (CHD) have an increased risk of adverse maternal and perinatal outcome. In many centers, pregnant women with complex heart diseases are supervised by a multidisciplinary team, creating an action-plan concerning pregnancy and delivery in order to reduce the risk to a minimum. Large studies concerning obstetric and perinatal outcome in women with CHD are lacking. The objective of this study was to assess the risk of adverse obstetric and perinatal outcome during delivery in women with CHD in a large cohort. STUDY DESIGN: We conducted a retrospective multicentre observational study, using the ZAHARA (Zwangerschap en Aangeboren HARtAfwijkingen, pregnancy and congenital heart disease) I-III databases. Women were categorized into 5 groups according to the WHO (World Health Organization) classification for maternal complications during pregnancy. These groups were compared with a control group. RESULTS: d 1190 women with CHD and 69 control patients were included from multiple Dutch and Belgian tertiary medical centres.
d Mode of delivery was associated with higher WHO groups, elective caesarean section rates are higher as compared to the control group (2.9%) and significant in WHO II-III (11.1%, p¼0.037) and III (22.2%, p<0.001), see table 1.
d The prevalence of small for gestational age (SGA) is higher in all WHO groups as compared to the control group (lower WHO group OR 4.1, CI 95% 1.27 e 13.3 and higher WHO group (II-III OR 3.9, CI 95% 1.2 e 12.7), see table 1 and 2.
d A higher WHO group (WHO II-III) is also associated with preterm birth (OR 3.4, CI 95% 1.2 e 9.7) and perinatal death (OR 1.03, CI 95% 1.01 e 1.04) as compared with the control group, see table 1 and 2. CONCLUSION: The prevalence of SGA is higher in all WHO groups. In addition, more complex CHD (higher WHO groups) are associated with increased rates of elective caesarean sections for cardiac reasons and perinatal complications as SGA, preterm birth and perinatal
